<?xml version="1.0" encoding="UTF-8"?>
<p>Two Gram-positive 
 <italic>bacteria Bacillus subtilis</italic> (ATCC6633) and 
 <italic>Staphylococcus aureus</italic> ATCC (25923) were used. The antibacterial assay and the determination of the minimum inhibitory concentration (MIC) were determined according to continuous dilution method in the 96-well plates. Compound 
 <bold>313</bold> showed antibacterial activity against 
 <italic>Bacillus subtilis</italic> with an MIC value of 12.5 Î¼g/mL. Ciprofloxacin was the positive control [
 <xref rid="B104-ijms-22-00959" ref-type="bibr">104</xref>].
</p>
